Lisa Von Moltke
About Lisa Von Moltke
Lisa Von Moltke is the EVP, Chief Medical Officer, with a medical degree from Michigan State University and a B.A. from Wellesley College. She has held significant roles in clinical development and pharmacology at several major pharmaceutical companies.
Lisa Von Moltke's Professional Title
Lisa Von Moltke holds the position of Executive Vice President (EVP) and Chief Medical Officer. In this role, she oversees various medical and clinical operations within the organization.
Lisa Von Moltke's Education Background
Lisa Von Moltke earned her Bachelor of Arts degree from Wellesley College. She subsequently obtained her Doctor of Medicine (M.D.) from the Michigan State University, College of Human Medicine. This educational foundation has significantly contributed to her extensive career in medical and clinical pharmacology.
Lisa Von Moltke's Career at Alkermes, Inc.
At Alkermes, Inc., Lisa Von Moltke served in various roles, culminating in her position as Senior Vice President and Head of Clinical Development. During her tenure, she contributed to the clinical development and strategic growth of the company.
Lisa Von Moltke's Role at Sanofi/Genzyme Corporation
Lisa Von Moltke held significant roles at Sanofi/Genzyme Corporation, including Vice President Clinical Pharmacology and U.S. Head Clinical & Exploratory Pharmacology Sciences (CEP) and Early Development. She later became the Head of CEP for the Japan and China regions, showcasing her leadership in global pharmacological sciences.
Leadership at Takeda Oncology Company by Lisa Von Moltke
Lisa Von Moltke served as the Head of Translational Medicine for Takeda Oncology Company. In this role, she was responsible for bridging experimental and clinical research to improve cancer treatments.
Professional Contributions to Clinical Pharmacology by Lisa Von Moltke
Lisa Von Moltke has been a prominent figure in clinical pharmacology, serving as President of the American College of Clinical Pharmacology. Additionally, she has contributed to the academic and research community as the Editor-in-Chief of The Journal of Clinical Pharmacology.